Schizophrenia
|
0.450 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study of schizophrenia in Ashkenazi Jews.
|
26198764 |
2015 |
Schizophrenia
|
0.450 |
GeneticVariation
|
disease |
GWASCAT |
Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
|
30285260 |
2019 |
Schizophrenia
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
Our findings suggest that the genetic variant in the CNNM2 gene could be implicated in the pathogenesis of schizophrenia through the GM volumetric vulnerability of the orbital regions in the inferior frontal gyri.
|
24160291 |
2013 |
Schizophrenia
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
We, therefore, used highly sensitive measures of allele-specific expression to assess cis-regulatory effects associated with the two best-supported schizophrenia risk variants (SNP rs11191419 and indel ch10_104957618_I/rs202213518) on the primary positional candidates BORCS7, AS3MT, CNNM2, and NT5C2 in the human brain.
|
27004590 |
2016 |
Schizophrenia
|
0.450 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study identifies five new schizophrenia loci.
|
21926974 |
2011 |
Schizophrenia
|
0.450 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study identifies five new schizophrenia loci.
|
21926974 |
2011 |
Schizophrenia
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
Although the biological role of CNNM2 in schizophrenia remains unknown, these data suggest that this CNNM2 risk variant rs7914558 may have an impact on neural systems relevant to social cognition.
|
24311551 |
2014 |
Schizophrenia
|
0.450 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia.
|
28991256 |
2017 |
Schizophrenia
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
The AO-analysis implicated the EGFR gene, as well as loci in other genes, in the AO variation of BP-type-I and revealed for the first time the link between BP-type-I and risk variants considered specific to schizophrenia (polymorphisms in MMP16/RIPK2 and CNNM2 genes).
|
26596365 |
2015 |
Schizophrenia
|
0.450 |
GeneticVariation
|
disease |
GWASCAT |
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
|
23453885 |
2013 |
Schizophrenia
|
0.450 |
Biomarker
|
disease |
PSYGENET |
Although the biological role of CNNM2 in schizophrenia remains unknown, these data suggest that this CNNM2 risk variant rs7914558 may have an impact on neural systems relevant to social cognition.
|
24311551 |
2014 |
Schizophrenia
|
0.450 |
Biomarker
|
disease |
BEFREE |
CNNM2 and NT5C2 are genes recently identified as susceptibility genes for schizophrenia in Europeans, but the exact mechanism by which these genes confer risk for schizophrenia remains unknown.
|
27401531 |
2016 |
Schizophrenia
|
0.450 |
Biomarker
|
disease |
PSYGENET |
Our findings suggest that the genetic variant in the CNNM2 gene could be implicated in the pathogenesis of schizophrenia through the GM volumetric vulnerability of the orbital regions in the inferior frontal gyri.
|
24160291 |
2013 |